However, peptides such as tigerinin-1R [20] and alyteserin-2a [21], which are partially deficient in antimicrobial activity, are able to promote the secretion of insulin, showing a potential for use in the treatment to type 2 diabetes. The gene discussed is INS; the disease is type 2 diabetes mellitus.